BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2304896)

  • 1. Amperozide--effect on prolactin release in the rat.
    Albinsson A; Eriksson E; Andersson G
    Pharmacol Toxicol; 1990; 66 Suppl 1():49-51. PubMed ID: 2304896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of the atypical antipsychotic drug, amperozide, on carrier-mediated striatal dopamine release measured in vivo.
    Yamamoto BK; Meltzer HY
    J Pharmacol Exp Ther; 1992 Oct; 263(1):180-5. PubMed ID: 1403783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amperozide and conditioned behaviour in rats: potentiation by classical neuroleptics and alpha-methylparatyrosine.
    Egbe P; Engel J; Gustafsson B; Christensson E
    Pharmacol Toxicol; 1990; 66 Suppl 1():18-21. PubMed ID: 1968251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amperozide--a new putatively antipsychotic drug with a limbic mode of action on dopamine mediated behaviour.
    Gustafsson B; Christensson E
    Pharmacol Toxicol; 1990; 66 Suppl 1():12-7. PubMed ID: 1968250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of amperozide on rat cortical 5-HT2 and striatal and limbic dopamine D2 receptor occupancy: implications for antipsychotic action.
    Meltzer HY; Zhang Y; Stockmeier CA
    Eur J Pharmacol; 1992 May; 216(1):67-71. PubMed ID: 1388121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of amperozide on uptake and release of [3H]-dopamine in vitro from perfused rat striatal and limbic brain areas.
    Eriksson E; Christensson E
    Pharmacol Toxicol; 1990; 66 Suppl 1():45-8. PubMed ID: 2304895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The putatively antipsychotic agent amperozide produces behavioural stimulation in the rat. A behavioural and biochemical characterization.
    Waters N; Pettersson G; Carlsson A; Svensson K
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Aug; 340(2):161-9. PubMed ID: 2572972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimal effects of JL 13, a pyridobenzoxazepine derivative with an antipsychotic potential, on circulating prolactin levels in male rats.
    LiƩgeois JF; Bruhwyler J; Hendrick JC; Delarge J; Legros JJ; Damas J
    Neurosci Lett; 2002 Feb; 319(1):49-52. PubMed ID: 11814651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of haloperidol on the synthesis of DNA in the pituitary gland of the rat.
    Machiavelli GA; Jahn GA; Kalbermann LE; Szijan I; Alonso GE; Burdman JA
    Horm Metab Res; 1982 Mar; 14(3):150-3. PubMed ID: 7068107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the novel antipsychotic agent 7-(4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro -2(1H)-quinolinone (OPC-14597) on prolactin release from the rat anterior pituitary gland.
    Inoue T; Domae M; Yamada K; Furukawa T
    J Pharmacol Exp Ther; 1996 Apr; 277(1):137-43. PubMed ID: 8613910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of amperozide on the dopamine synthesis activity in the tuberoinfundibular neurons.
    Andersson G; Albinsson A; Pettersson G
    Arzneimittelforschung; 1990 Mar; 40(3):237-9. PubMed ID: 2111999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amperozide and emotional behaviour.
    Gustafsson B; Christensson E
    Pharmacol Toxicol; 1990; 66 Suppl 1():34-9. PubMed ID: 2304894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flunarizine, a calcium influx blocker, inhibits TRH-but not potassium-stimulated prolactin secretion.
    Merritt JE; Tomlinson S; Brown BL
    Acta Endocrinol (Copenh); 1984 Sep; 107(1):31-5. PubMed ID: 6435368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease of prolactin secretion via stimulation of pituitary dopamine D-2 receptors after application of talipexole and SND 919.
    Domae M; Yamada K; Hanabusa Y; Matsumoto S; Furukawa T
    Eur J Pharmacol; 1990 Apr; 179(1-2):75-82. PubMed ID: 2142088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressive effect of prostaglandin D2 on prolactin secretion from rat anterior pituitary.
    Arisawa M; Makino T; Izumi S; Iizuka R
    Asia Oceania J Obstet Gynaecol; 1985 Mar; 11(1):127-30. PubMed ID: 3860198
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of prolactin release from anterior pituitary lactotrophs in culture by sulfur-containing analogs of dopamine.
    Ross PC; Burkman AM
    Proc Soc Exp Biol Med; 1988 May; 188(1):87-91. PubMed ID: 3368483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiological concentrations of dopamine decrease adenosine 3',5'-monophosphate levels in cultured rat anterior pituitary cells and enriched populations of lactotrophs: evidence for a causal relationship to inhibition of prolactin release.
    Swennen L; Denef C
    Endocrinology; 1982 Aug; 111(2):398-405. PubMed ID: 6284477
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibitory effects of endothelin-1 and endothelin-3 on prolactin release: possible involvement of endogenous endothelin isopeptides in the rat anterior pituitary.
    Domae M; Yamada K; Hanabusa Y; Furukawa T
    Life Sci; 1992; 50(10):715-22. PubMed ID: 1738298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolactin release from subpopulations of rat lactotrophs in the presence and absence of dopamine.
    Hu L; Lawson DM
    J Endocrinol; 1996 Jan; 148(1):113-20. PubMed ID: 8568458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of THIP and SL 76002, two clinically experimented GABA-mimetic compounds, on anterior pituitary GABA receptors and prolactin secretion in the rat.
    Apud JA; Masotto C; Racagni G
    Life Sci; 1987 Mar; 40(9):871-81. PubMed ID: 3029529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.